Goldman Sachs upgrades Nexans to Buy on stronger HVDC market
The bank raised its price target on Nexans shares to €125, implying about 15% upside from current levels.
Goldman expects the HVDC market to remain undersupplied beyond 2027, driven by accelerating demand for grid expansion projects across Europe. Its revised forecasts, based on the EU's 2024 Ten-Year Network (LON:NETW) Development Plan, show HVDC demand rising at a 10% compound annual rate through 2032—outpacing supply growth of just 6%.
Analysts now see demand exceeding supply by at least 20% from 2027 onwards, with supply additions from new entrants have been slower than initially expected.
Nexans, which recently reported a rebound in its order backlog, is seen as a key beneficiary of the supply-constrained market in the medium term, especially given improving utilization and project mix after 2026.
Shares in Nexans are up around 25% year-to-date. The company has positioned itself as a major supplier for energy transition infrastructure, including offshore wind and interconnector projects, amid a broader push to modernize Europe's power grid.
The HVDC segment has attracted rising investor interest amid growing policy support for grid resilience and decarbonization. Rivals such as Prysmian (BIT:PRY) and NKT have also flagged strong order pipelines and capacity expansions, though Goldman highlighted delays among newer players.
Nexans is scheduled to report first-half results later this month.
Related articles
Goldman Sachs upgrades Nexans to Buy on stronger HVDC market
Apple: Citi says June demand pull-in leads to more uncertainties in H2
Is the market too hot? Yardeni weighs risks of correction or worse
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
a minute ago
- Associated Press
Comcast to Participate in Goldman Sachs Investor Conference
PHILADELPHIA--(BUSINESS WIRE)--Aug 19, 2025-- Comcast Corporation (Nasdaq: CMCSA) announced that on Tuesday, September 9, 2025, Mike Cavanagh, President of Comcast Corporation, will participate in the Goldman Sachs Communacopia + Technology Conference. A live webcast of the event will be available on the Company's Investor Relations website at on Tuesday, September 9, 2025, at 11:10 A.M. Eastern Time. An on-demand replay will be available shortly after the conclusion of the presentation. To automatically receive Comcast financial news by e-mail, please visit and subscribe to E-mail Alerts. View source version on CONTACT: Investor Contacts: Marci Ryvicker (215) 286-4781 Jane Kearns (215) 286-4794 Marc Kaplan (215) 286-6527 Press Contacts: Jennifer Khoury (215) 286-7408 John Demming (215) 286-8011 KEYWORD: UNITED STATES NORTH AMERICA PENNSYLVANIA INDUSTRY KEYWORD: ENTERTAINMENT COMMUNICATIONS TECHNOLOGY TV AND RADIO TELECOMMUNICATIONS MEDIA CARRIERS AND SERVICES SOURCE: Comcast Corporation Copyright Business Wire 2025. PUB: 08/19/2025 03:00 PM/DISC: 08/19/2025 03:00 PM
Yahoo
an hour ago
- Yahoo
Amer Sports Raises Annual Outlook, Analysts Probe China Strength
Amer Sports, Inc. (NYSE:AS) shares are trading lower on Tuesday. The company reported second-quarter adjusted earnings per share of 6 cents, beating the analyst consensus estimate of 3 cents. Quarterly sales of $1.24 billion (+23% year over year) outpaced the Street view of $1.18 Sachs analyst Brooke Roach reiterated the Buy rating on Amer Sports, with a price forecast of $45. According to Roach, Amer Sports delivered strong results despite high investor expectations, with a solid beat and raised annual outlook even as tariffs posed a headwind. He noted Salomon brand drove the outperformance, showing sequential acceleration despite tougher comparisons, with omni-channel sales up 28%, operating profit up 35% year-over-year, and margins expanding over 700 basis points. However, Technical Apparel growth was more in line with expectations, with comps at +15% but showing slower sequential growth. Roach added that Greater China momentum and DTC strength were highlights, while management's third-quarter revenue guidance above consensus signals continued momentum into the next quarter. Roach highlighted key downside risks for Amer Sports, including slower-than-expected growth in Greater China, weaker brand momentum if innovation slows, and potential concerns around the corporate structure such as its Cayman Islands incorporation and changes in backing from major shareholders. The analyst also pointed to risks from limited or lower-quality real estate availability. Roach said that the team will look for more detail on the call regarding revenue drivers by geography and channel, focusing on the durability of China's growth momentum and the slight sequential slowdown in the Americas. The analyst added they also want an update on management's view of Arc'teryx's comp potential across regions and the related margin flow-through opportunity. Price Action: AS shares are trading lower by 6.28% to $35.15 at last check Tuesday. Read now:Photo via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Amer Sports Raises Annual Outlook, Analysts Probe China Strength originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved.
Business Wire
3 hours ago
- Business Wire
Number of Shares and Voting Rights of ADOCIA as of July 31 st, 2025
LYON, France--(BUSINESS WIRE)--Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French 'Code de Commerce' and article 223-16 of the General Regulation of the French stock-market authorities (Autorité des Marchés Financiers, or 'AMF'), ADOCIA SA (Paris:ADOC), a French société anonyme (corporation), 115, avenue Lacassagne, 69003 Lyon, (Euronext Paris: FR0011184241 – ADOC) a clinical-stage biopharmaceutical Company focused on the research and development of innovative therapeutic solutions for the treatment of diabetes and obesity, releases its total number of outstanding shares as well as its voting rights as of July 31 st, 2025. (1) The total number of theoretical voting rights is used as the basis for calculating the crossing of shareholding thresholds. In accordance with Article 223-11 of the AMF General Regulation, this number is calculated on the basis of all shares to which voting rights are attached, including shares whose voting rights have been suspended. (2) The total number of exercisable voting rights is calculated without taking into account the shares with suspended voting rights, in this case, shares held by the Company in the context of a liquidity agreement. It is provided for the information of the public, in accordance with the AMF recommendation of July 17, 2007. About Adocia Adocia is a biotechnology company specializing in the discovery and development of therapeutic solutions in the field of metabolic diseases, primarily diabetes and obesity. The Company has a broad portfolio of drug candidates based on four proprietary technology platforms: 1) The BioChaperone ® technology for the development of new generation insulins and products combining different hormones; 2) AdOral ®, an oral peptide delivery technology; 3) AdoShell ®, an immunoprotective biomaterial for cell transplantation, with an initial application in pancreatic cells transplantation; and 4) AdoGel ®, a long-acting drug delivery platform. Adocia holds more than 25 patent families. Based in Lyon, the company has about 80 employees. Adocia is listed on the regulated market of Euronext™ Paris (Euronext: ADOC; ISIN: FR0011184241).
